Keenova Therapeutics plc announced the first-time publication of a retrospective analysis using previously generated XIAFLEX® (collagenase clostridium histolyticum) data. The analysis evaluates ...

Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

Melbourne researchers have successfully tested a new therapy for a complex and increasingly common eating disorder among teenagers. The study found that an enhanced treatment model, developed by ...

NYU Langone Health, a major Manhattan hospital, will permanently ax its transgender treatment program for kids after the Trump administration threatened to pull federal funding. The hospital is ...

The FDA granted the approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies.

Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms ...

NYU Langone Health cited the “current regulatory environment” in its decision to discontinue its gender medicine program for minors. By Joseph Goldstein A major Manhattan hospital, faced with threats ...

One person’s recreational drug trip might be another’s mental health boost. Research out today finds that dimethyltryptamine, better known as DMT, could be effective at treating people’s depression.

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease ...

The FDA accepted a New Drug Application with Priority Review for brepocitinib, an oral TYK2/JAK1 inhibitor, for the treatment of dermatomyositis.